Uncategorized

  1. Health & Medicine

    Do Over: New MS drug may be safe after all

    The experimental drug natalizumab, which limits relapses in patients with multiple sclerosis, may get a second chance after being withdrawn from use in 2005.

    By Nathan Seppa

  2. 19649

    This article contained a very disturbing comment: “Neurologist Annette Langer-Gould of Stanford University says that even the 1-in-1,000 risk of PML [leukemia] ‘seems to outweigh the benefits’ that natalizumab would provide many patients.” Having a genetic mutation for which there is no treatment or cure and having (and having had) friends with MS, I am […]

    By Science News
  3. Humans

    Letters from the March 4, 2006, issue of Science News

    Impure thoughts Epidemiologist Scott Davis warns, “Melatonin supplements are not regulated” the way drugs are.